Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone Pre-dosing vs Concurrent Dosing with Furosemide
NCT03746002Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metolazone in heart failure (HF), sponsored by University of Maryland, Baltimore. Started Jan 2019; status: terminated.
02
Drugs
metolazone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03746002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746002.